Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.
作者信息
Kogut Neil, Tsai Ni-Chun, Thomas Sandra H, Palmer Joycelynne, Paris Tanya, Murata-Collins Joyce, Forman Stephen J
出版信息
Leuk Lymphoma. 2013 Mar;54(3):665-8. doi: 10.3109/10428194.2012.720375. Epub 2012 Sep 12.
Abstract
摘要
相似文献
1
Extramedullary relapse following reduced intensity allogeneic hematopoietic cell transplant for adult acute myelogenous leukemia.成人急性髓性白血病接受减低强度异基因造血细胞移植后的髓外复发
Leuk Lymphoma. 2013 Mar;54(3):665-8. doi: 10.3109/10428194.2012.720375. Epub 2012 Sep 12.
2
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后骨髓增生异常综合征（MDS）及MDS继发急性髓系白血病的个体预后预测
Ann Hematol. 2017 Aug;96(8):1361-1372. doi: 10.1007/s00277-017-3027-5. Epub 2017 Jun 13.
3
Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.异基因造血干细胞移植后急性髓系白血病髓外复发：发生率、危险因素和结局。
Haematologica. 2013 Feb;98(2):179-84. doi: 10.3324/haematol.2012.073189. Epub 2012 Oct 12.
4
Extramedullary relapse of acute leukemia after allogeneic hematopoietic stem cell transplantation: different characteristics between acute myelogenous leukemia and acute lymphoblastic leukemia.异基因造血干细胞移植后急性白血病的髓外复发：急性髓系白血病与急性淋巴细胞白血病的不同特征
Biol Blood Marrow Transplant. 2014 Jul;20(7):1040-7. doi: 10.1016/j.bbmt.2014.03.030. Epub 2014 Apr 2.
5
Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.CD25表达对细胞遗传学中危急性髓系白血病异基因造血干细胞移植结局的临床影响
Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. Epub 2014 Nov 14.
6
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.在原发性诱导失败或首次复发后进行挽救性异体干细胞移植的 141 例核型正常的急性髓细胞白血病患者中，分子亚群对预后的影响。
Haematologica. 2013 Apr;98(4):518-25. doi: 10.3324/haematol.2012.070235. Epub 2012 Sep 14.
7
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
8
Extramedullary Relapse of Acute Myelogenous Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后急性髓系白血病髓外复发。
Biol Blood Marrow Transplant. 2019 Jun;25(6):1152-1157. doi: 10.1016/j.bbmt.2019.01.011. Epub 2019 Jan 17.
9
Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia.在急性髓系白血病的异基因造血干细胞移植后，早期巨细胞病毒复制及随后的慢性移植物抗宿主病具有显著的抗白血病作用。
Ann Hematol. 2015 Feb;94(2):275-82. doi: 10.1007/s00277-014-2190-1. Epub 2014 Aug 20.
10
Outcome of patients with abnl(17p) acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.伴有 abnl(17p) 的急性髓系白血病患者在异基因造血干细胞移植后的结果。
Blood. 2014 May 8;123(19):2960-7. doi: 10.1182/blood-2013-12-544957. Epub 2014 Mar 20.
引用本文的文献
1
Diagnostic Approaches in Myeloid Sarcoma.髓系肉瘤的诊断方法
Curr Issues Mol Biol. 2025 Feb 10;47(2):111. doi: 10.3390/cimb47020111.
2
Myeloid Sarcoma: Novel Advances Regarding Molecular Pathogenesis, Presentation and Therapeutic Options.髓系肉瘤：关于分子发病机制、临床表现及治疗选择的新进展
J Clin Med. 2024 Oct 16;13(20):6154. doi: 10.3390/jcm13206154.
3
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome.AML 患者在接受 HLA 匹配移植的序贯 RIC 治疗中发生髓外疾病的影响：发生率、危险因素、复发模式和结局。
Ann Hematol. 2023 Aug;102(8):2213-2223. doi: 10.1007/s00277-023-05281-8. Epub 2023 Jun 10.
4
Myeloid sarcoma: more and less than a distinct entity.骨髓肉瘤：不只是一个明确的实体。
Ann Hematol. 2023 Aug;102(8):1973-1984. doi: 10.1007/s00277-023-05288-1. Epub 2023 Jun 7.
5
Circular RNA regulatory network reveals cell-cell crosstalk in acute myeloid leukemia extramedullary infiltration.环状 RNA 调控网络揭示急性髓系白血病髓外浸润中的细胞间串扰。
J Transl Med. 2018 Dec 17;16(1):361. doi: 10.1186/s12967-018-1726-x.
6
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.复发/难治性急性白血病患者全骨髓和淋巴照射移植预处理的I期试验
Biol Blood Marrow Transplant. 2017 Apr;23(4):618-624. doi: 10.1016/j.bbmt.2017.01.067. Epub 2017 Jan 10.
7
Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome.急性髓系白血病的异基因造血细胞移植：移植前髓外疾病对预后无影响。
Bone Marrow Transplant. 2015 Aug;50(8):1057-62. doi: 10.1038/bmt.2015.82. Epub 2015 Apr 27.
本文引用的文献
1
Isolated Extramedullary Relapse of Acute Leukemia after Allogeneic Stem Cell Transplantation: Different Kinetics and Better Prognosis than Systemic Relapse.异基因造血干细胞移植后急性白血病的孤立性髓外复发：与系统性复发相比，具有不同的动力学和更好的预后。
Biol Blood Marrow Transplant. 2017 Jul;23(7):1087-1094. doi: 10.1016/j.bbmt.2017.03.023. Epub 2017 Apr 7.
2
Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome.异基因单倍体造血干细胞移植治疗晚期急性髓系白血病/骨髓增生异常综合征后髓外复发的发生率。
Bone Marrow Transplant. 2012 May;47(5):669-76. doi: 10.1038/bmt.2011.163. Epub 2011 Aug 22.
3
Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse.异基因造血干细胞移植后急性髓系白血病髓外复发：预后优于全身复发。
Biol Blood Marrow Transplant. 2012 Jan;18(1):106-12. doi: 10.1016/j.bbmt.2011.05.023. Epub 2011 Jun 12.
4
Extramedullary sites of leukemia relapse after transplant.移植后白血病复发的髓外部位。
Leuk Lymphoma. 2006 Sep;47(9):1754-67. doi: 10.1080/10428190600632857.
5
Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning.非清髓性预处理造血干细胞移植后髓外白血病复发
Int J Hematol. 2005 Oct;82(3):262-5. doi: 10.1532/IJH97.04195.
6
Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course.异基因造血细胞移植后急性白血病的骨髓复发与髓外复发：危险因素及临床病程
Bone Marrow Transplant. 2003 Oct;32(8):835-42. doi: 10.1038/sj.bmt.1704223.
7
8
Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.存在竞争风险时失败概率的估计：旧估计量的新表示形式。
Stat Med. 1999 Mar 30;18(6):695-706. doi: 10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o.
9
High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation.白消安/环磷酰胺预处理及异基因干细胞移植后急性髓系白血病髓外复发的高发生率。
Bone Marrow Transplant. 1998 Aug;22(3):259-64. doi: 10.1038/sj.bmt.1701319.
10
Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and Chronic Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.异基因骨髓移植后粒细胞肉瘤：一项欧洲多中心回顾性调查。欧洲血液和骨髓移植组急性和慢性白血病工作组
Bone Marrow Transplant. 1996 May;17(5):801-8.
Zotero 插件